Skip to main content
Fig. 6 | Molecular Medicine

Fig. 6

From: Part I: Pathogenetic Role of Peroxynitrite in the Development of Diabetes and Diabetic Vascular Complications: Studies With FP15, A Novel Potent Peroxynitrite Decomposition Catalyst

Fig. 6

Reversal of streptozotocin-evoked diabetes-induced diastolic cardiac dysfunction by FP15 in mice. Effect of diabetes (9–10 weeks) and FP15 treatment in diabetic mice on left ventricular end diastolic pressure (LVEDP) and left ventricular −dp/dt (LV −dp/dt). Results are mean ± SEM of seven experiments in each group. *p < 0.05 diabetic animals versus control; #p < 0.05 in FP15-treated diabetic mice versus vehicle-treated diabetic mice.

Back to article page

Molecular Medicine

ISSN: 1528-3658